Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo

作者: JING ZHANG , YU-BIN KOU , JIN-SHUI ZHU , WEI-XIONG CHEN , SHUANG LI

DOI: 10.3892/IJO.2014.2285

关键词: Cell growthOncogeneIn vivoCancer researchGene knockdownNude mouseCancer cellCell cycleBiologySmall hairpin RNA

摘要: High mobility group box 1 (HMGB1) as a novel inflammatory molecule has been shown to be involved in variety of cell physiological and pathological behaviors including immune response, inflammation cancer. Evidence suggests that HMGB1 plays critical role the development progression multiple malignancies. However, underlying molecular mechanisms for HMGB1-mediated growth invasion gastric cancer have not yet elucidated. The present study investigated expression adenocarcinoma (GAC) by which it contributes tumor invasion. correlation between clinicopathological characteristics GAC patients was assessed immunohistochemical assay through tissue microarray procedures. RNA protein expressions downstream factors were detected quantitative PCR western blot assays; proliferation determined MTT, wound-healing 3D-Matregel assays, subcutaneous SGC-7901 models established verify vivo. We demonstrated that, significantly increased nucleus tissues compared with adjacent non-cancer (88.6 vs.70.5%, P<0.001), correlated metastatic lymph node (P=0.018). Furthermore, knockdown shRNA inhibited proliferative activities invasive potential, downregulated NF-κB p65, PCNA MMP-9 cells (SGC-7901 AGS). volumes SGC7901 nude mouse treated Lv-shHMGB1 smaller than those nonsense sequence group. Taken together, these findings suggest is associated metastasis GAC, suppresses pathway vitro vivo, suggesting may serve potential therapeutic target GAC.

参考文章(35)
Min Koo Lee, Han Young Choi, June Choi, Kwang Yoon Jung, Seung Kuk Baek, Kyoung Ho Oh, Yeon Soo Kim, Jeong Soo Woo, Soon Young Kwon, Seung Hoon Lee, Interaction effect between the receptor for advanced glycation end products (RAGE) and high-mobility group box-1 (HMGB-1) for the migration of a squamous cell carcinoma cell line. Tumori. ,vol. 97, pp. 196- 202 ,(2011) , 10.1700/667.7783
Patrick Wefstaedt, Jörn Bullerdiek, Sven Kleinschmidt, Nina Eberle, Ingo Nolte, Katharina A. Sterenczak, Hugo Murua Escobar, Marion Hewicker-Trautwein, Quantitative PCR and Immunohistochemical Analyses of HMGB1 and RAGE Expression in Canine Disseminated Histiocytic Sarcoma (Malignant Histiocytosis) Anticancer Research. ,vol. 31, pp. 1541- 1548 ,(2011)
Paladd Asavarut, Hailin Zhao, Jianteng Gu, Daqing Ma, The role of HMGB1 in inflammation-mediated organ injury Acta Anaesthesiologica Taiwanica. ,vol. 51, pp. 28- 33 ,(2013) , 10.1016/J.AAT.2013.03.007
STEFANIA MARDENTE, EMANUELA MARI, FABRIZIO CONSORTI, CIRA DI GIOIA, RODOLFO NEGRI, MARILENA ETNA, ALESSANDRA ZICARI, ALFREDO ANTONACI, HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells. Oncology Reports. ,vol. 28, pp. 2285- 2289 ,(2012) , 10.3892/OR.2012.2058
Hui Weng, Yunhua Deng, Yuyan Xie, Hongbo Liu, Feili Gong, Expression and significance of HMGB1, TLR4 and NF-κB p65 in human epidermal tumors. BMC Cancer. ,vol. 13, pp. 311- 311 ,(2013) , 10.1186/1471-2407-13-311
J R van Beijnum, P Nowak-Sliwinska, E van den Boezem, P Hautvast, W A Buurman, A W Griffioen, Tumor angiogenesis is enforced by autocrine regulation of high-mobility group box 1 Oncogene. ,vol. 32, pp. 363- 374 ,(2013) , 10.1038/ONC.2012.49
Tim E. Cawston, Amy J. Wilson, Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Practice & Research: Clinical Rheumatology. ,vol. 20, pp. 983- 1002 ,(2006) , 10.1016/J.BERH.2006.06.007
WEI WANG, HAOWEN JIANG, HECHEN ZHU, HU ZHANG, JIAN GONG, LIMIN ZHANG, QIANG DING, Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma Oncology Letters. ,vol. 5, pp. 884- 888 ,(2013) , 10.3892/OL.2012.1091
Xingjun Yao, Gang Zhao, Hongfa Yang, Xinyu Hong, Li Bie, Guojin Liu, Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma. Journal of Cancer Research and Clinical Oncology. ,vol. 136, pp. 677- 684 ,(2010) , 10.1007/S00432-009-0706-1
Jie Chen, Bo Xi, Yueran Zhao, Yang Yu, Jie Zhang, Chunyu Wang, High-mobility group protein B1 (HMGB1) is a novel biomarker for human ovarian cancer. Gynecologic Oncology. ,vol. 126, pp. 109- 117 ,(2012) , 10.1016/J.YGYNO.2012.03.051